Actinium Pharmaceuticals stock price
악티늄 파머슈티컬스NYSEAMERICAN:ATNM · NYSE Amex · Healthcare$1.17+1.74%
2026-10-02 closeLoading chart…
Today's signals · No active technical signal.
Signal details →Actinium Pharmaceuticals last closed at $1.17 (+1.74%) on 2026-10-02. Listed on NYSE Amex. Trailing 12 months PER is 3.2×. Its overall grade ranks 61 of 739 stocks in Healthcare.
About this company
Actinium Pharmaceuticals last closed at $1.17 (+1.74%) on 2026-10-02. Listed on NYSE Amex.
Details →Reported results
Details →
Position in sector
Healthcare · Overall A+ · 61/739
Valuation grade B-
Related stocks
- AstraZenecaCompetitor
방사성의약품·표적항암 치료제 개발 영역에서 경쟁 가능성이 큼
- NovartisCompetitor
방사성의약품 및 혈액암 치료제 개발 경쟁사로 자주 비교됨
- Bristol-Myers SquibbCompetitor
혈액암·면역항암 치료제 시장에서 대형 경쟁사
About Actinium Pharmaceuticals
- What technical signals does Actinium Pharmaceuticals (ATNM) have?
- Actinium Pharmaceuticals current technical signals: no active technical signal.
- Is Actinium Pharmaceuticals a cup-and-handle pattern?
- No. Actinium Pharmaceuticals has no valid Cup signal right now.
- What published figures are available for Actinium Pharmaceuticals?
- Market cap: $36.5M. Trailing 12 months PER: 3.2×. Latest quarter PBR: 1.21×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Turn what you saw on this name into a strategy
Ask Q about Actinium Pharmaceuticals, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.
Quantus Signal · live data · not investment advice · Privacy Policy